Lexeo Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
LXEO
CUSIP
52886X107
Type
Equity
Class
COM
Num filings
72
Total reported value, excl. options
$270 M
Manager Report Date Value ($000) Shares Option Type